RECORDATI ANNOUNCES GROWTH IN THE FIRST HALF 2019. REVENUES +6.8%, EBITDA(1) +7.4%, NET INCOME +6.1%

World News: . []

In February Recordati LINK  a license agreement with LINK  Pharmaceuticals Inc for the exclusive rights to commercialize Juxtapidreg LINK  approved for the treatment of homozygous LINK  hypercholesterolemia HoFH in Japa...

More news and information about RECORDATI

Published By:

Globe Newswire: 12:21 GMT Tuesday 30th July 2019

Published: .

Search for other references to "recordati" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us